{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2004"],"condition":["Solid Malignancies","Lymphoma, Non-Hodgkin","Pancreatic cancer","Non-Hodgkin's Lymphoma","Colorectal cancer","Head and neck cancer","Breast cancer","Prostate cancer","Bladder cancer","Lymphoma","Neoplasms","Ovarian cancer"],"disease":["Ovarian Cancer","Non-hodgkin's Lymphoma","Solid Malignancies","Colorectal Cancer","Prostate Cancer","Bladder Cancer","Lymphoma, Non-hodgkin","Head And Neck Cancer","Pancreatic Cancer","Lymphoma","Breast Cancer","Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2011348"],"location":["United States"],"study_start_month":["8"],"keyword":["Diffuse","Acute myelogenous leukemia","Chronic lymphocytic leukemia","AQ4N","Hypoxia","Metastatic","Follicular"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin’s Lymphoma","description":"The purposes of this study are to determine:\n* the largest dose of AQ4N that can be safely given once a week for three weeks out of a 4 week cycle\n* the side effects of AQ4N when given on the above schedule\n* how much AQ4N is in the blood and urine at specific times after administration and how the body get rids of AQ4N\n* if AQ4N helps treat cancer","dates":{"creation":"2004-08-15"},"accession":"2011348","cross_references":{"ClinicalTrials___gov":["NCT00090727"]}}